Testing effectiveness (Phase 2)Study completedNCT02401815
What this trial is testing
CGT9486 (Formerly Known as PLX9486) as a Single Agent and in Combination With PLX3397 (Pexidartinib) or Sunitinib in Participants With Advanced Solid Tumors
Who this might be right for
Gastrointestinal Stromal Tumors
Cogent Biosciences, Inc. 51